Seizure Risk following Open and Expanded Endoscopic Endonasal Approaches for Intradural Skull Base Tumors. Journal of neurological surgery. Part B, Skull base Goldschmidt, E. n., Chabot, J. D., Algattas, H. n., Lieber, S. n., Khattar, N. n., Nakassa, A. C., Angriman, F. n., Snyderman, C. H., Wang, E. W., Fernandez-Miranda, J. C., Gardner, P. A. 2020; 81 (6): 673–79


Objectives The incidence of seizures following a craniotomy for tumor removal varies between 15 and 20%. There has been increased use of endoscopic endonasal approaches (EEAs) for a variety of intracranial lesions due to its more direct approach to these pathologies. However, the incidence of postoperative seizures in this population is not well described. Methods This is a single-center, retrospective review of consecutive patients undergoing EEA or open craniotomy for resection of a cranial base tumor between July 2007 and June 2014. Patients were included if they underwent an EEA for an intradural skull base lesion. Positive cases were defined by electroencephalograms and clinical findings. Patients who underwent a craniotomy to remove extra-axial skull base tumors were analyzed in the same fashion. Results Of the 577 patients treated with an EEA for intradural tumors, 4 experienced a postoperative seizure (incidence 0.7%, 95% confidence interval [CI]: 0.002-0.02). Over the same period, 481 patients underwent a craniotomy for a skull base lesion of which 27 (5.3%, 95% CI: 0.03-0.08) experienced a seizure after surgery. The odds ratio for EEA was 0.13 (95% CI: 0.05-0.35). Both populations were different in terms of age, gender, tumor histology, and location. Conclusion This study is the largest series looking at seizure incidence after EEA for intracranial lesions. Seizures are a rare occurrence following uncomplicated endonasal approaches. This must be tempered by selection bias, as there are inherent differences in which patients are treated with either approach that influence the likelihood of seizures.

View details for DOI 10.1055/s-0039-1694968

View details for PubMedID 33381372

View details for PubMedCentralID PMC7755514